Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 1;17(4):292-296.
doi: 10.1002/cld.1046. eCollection 2021 Apr.

Hepatic Manifestations of Inflammatory Bowel Disease

Affiliations
Review

Hepatic Manifestations of Inflammatory Bowel Disease

Parita Patel et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

FIG 1
FIG 1
Algorithm for the diagnosis of PSC. Adapted with permission from Hepatology. 2 Copyright 2010, American Association for the Study of Liver Diseases.
FIG 2
FIG 2
Diagnostic approach to abnormal liver function tests in a patient with IBD. Reprinted with permission from Liver International. 4 Copyright 2017, John Wiley & Sons A/S.

References

    1. Mendes FD, Levy C, Enders FB, et al. Abnormal hepatic biochemistries in patients with inflammatory bowel disease. Am J Gastroenterol 2007;102:344‐350. - PubMed
    1. Chapman R, Fevery J, Kalloo A, et al. Diagnosis and management of primary sclerosis cholangitis. Hepatology 2010;51:660‐678. - PubMed
    1. Palmela C, Peerani F, Castaneda D, et al. Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features. Gut Liver 2018;12:17‐29. - PMC - PubMed
    1. Restellini S, Chazouillères O, Frossard JL. Hepatic manifestations of inflammatory bowel diseases. Liver Int 2017;37:475‐489. - PubMed
    1. European Association for the Study of the Liver . EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol 2009;51:237‐267. - PubMed